𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cells

✍ Scribed by Gary E. Meyer; Louis Chesler; Dandan Liu; Karissa Gable; Betty A. Maddux; David D. Goldenberg; Jack F. Youngren; Ira D. Goldfine; William A. Weiss; Katherine K. Matthay; Stephen M. Rosenthal


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
304 KB
Volume
102
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Neuroblastoma is a common pediatric malignancy that metastasizes to the liver, bone, and other organs. Children with metastatic disease have a less than 50% chance of survival with current treatments. Insulin‐like growth factors (IGFs) stimulate neuroblastoma growth, survival, and motility, and are expressed by neuroblastoma cells and the tissues they invade. Thus, therapies that disrupt the effects of IGFs on neuroblastoma tumorigenesis may slow disease progression. We show that NVP‐AEW541, a specific inhibitor of the IGF‐I receptor (IGF‐IR), potently inhibits neuroblastoma growth in vitro. Nordihydroguaiaretic acid (NDGA), a phenolic compound isolated from the creosote bush (Larrea divaricata), has anti‐tumor properties against a number of malignancies, has been shown to inhibit the phosphorylation and activation of the IGF‐IR in breast cancer cells, and is currently in Phase I trials for prostate cancer. In the present study in neuroblastoma, NDGA inhibits IGF‐I‐mediated activation of the IGF‐IR and disrupts activation of ERK and Akt signaling pathways induced by IGF‐I. NDGA inhibits growth of neuroblastoma cells and induces apoptosis at higher doses, causing IGF‐I‐resistant activation of caspase‐3 and a large increase in the fraction of sub‐G~0~ cells. In addition, NDGA inhibits the growth of xenografted human neuroblastoma tumors in nude mice. These results indicate that NDGA may be useful in the treatment of neuroblastoma and may function in part via disruption of IGF‐IR signaling. J. Cell. Biochem. 102: 1529–1541, 2007. © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Fibroblast growth factor-2 over-rides in
✍ Vincenzo C. Russo; E. Andaloro; S.A. Fornaro; S. Najdovska; D.F. Newgreen; L.A. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB

## Abstract The insulin‐like growth factor (IGF) system is a key regulator of cell growth, survival and differentiation, and these functions are co‐modulated by other growth factors including fibroblast growth factor‐2 (FGF‐2). To investigate IGF/FGF interactions in neuronal cells, we employed neur

Soluble insulin-like growth factor II/ma
✍ Carolyn D. Scott; Jocelyn Weiss 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

The soluble form of the insulin-like growth factor II (IGF-II)/mannose 6-P (IGF-II/ M6P) receptor is released by cells in culture and circulates in the serum. It retains its ability to bind IGF-II and blocks IGF-II-stimulated DNA synthesis in isolated rat hepatocytes. Because these cells are not nor

Insulin-like growth factor-binding prote
✍ Nicole M. Kühl; Dick Hoekstra; Hans De Vries; Jacques De Keyser 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB

## Abstract Insulin‐like growth factor 1 (IGF‐1) is a growth and survival factor for oligodendrocyte lineage cells and promotes myelination. We demonstrate that IGF‐binding protein 6 (IGFBP‐6) is expressed and localized to the Golgi complex in rat oligodendrocyte precursor (O2A) cells. IGFBP‐6 mRNA

Insulin-like growth factor I is the key
✍ Cynthia M. Van Golen; Eva L. Feldman 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 2 views

Neuroblastoma is a childhood tumor of the peripheral nervous system that remains largely uncurable by conventional methods. Mannitol induces apoptosis in neuroblastoma cell types and insulin-like growth factor I (IGF-I) protects these cells from hyperosmotic-induced apoptosis by affecting apoptosis-

Insulin-like growth factor binding prote
✍ Nicole M. Kühl; Jacques De Keyser; Hans De Vries; Dick Hoekstra 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

Insulin-like growth factor-1 (IGF-1) is a growth and survival factor for oligodendrocyte lineage cells and induces myelination. Its actions are modulated by IGF binding proteins (IGFBPs) that are present in the extracellular fluids or on the cell surface. Additionally, IGFBPs are also known to exert